Over 5 million RT-PCR tests for COVID-19 conducted by ICMR until 9 June; council increases testing capacity to 1.4 lakh per day

Till 6 June, a total of 50, 30,700 COVID-19 samples were tested across the country. Another 1, 41,682 have been tested in the past 24 hours, ICMR officials said.

Asian News International June 10, 2020 08:58:24 IST
Over 5 million RT-PCR tests for COVID-19 conducted by ICMR until 9 June; council increases testing capacity to 1.4 lakh per day

New Delhi: Over five million RT-PCR tests to detect SARS-CoV-2 - the virus behind COVID-19 pandemic - have been done across the country, India Council of Medical Research (ICMR) has said.

Till 6 June, a total of 50, 30,700 samples were tested across the country. Another 1, 41,682 have been tested in the past 24 hours, ICMR officials said.

"We have increased the testing capacity to 1.4 lakh per day. So far, we have 789 laboratories (553 government and 231 private labs). A total of 50, 30,700 samples have been tested till 6 June evening," an ICMR official said.

According to the Union Health Ministry, India reported a total of 9,987 coronavirus cases in the past 24 hours. The toll due to COVID-19 has risen to 7,466 and the total number of cases has risen to 2, 66,598.

Updated Date:

also read

COVID-19 booster dose not central theme at the moment, double shot priority: ICMR
India

COVID-19 booster dose not central theme at the moment, double shot priority: ICMR

Union Health Secretary Rajesh Bhushan said 20 percent of India's adult population have received both doses of COVID-19 vaccine and 62 percent have got at least one dose

Beijing Winter Olympics: IOC urges teams to ask for more vaccines ahead of next year's Games
Sports

Beijing Winter Olympics: IOC urges teams to ask for more vaccines ahead of next year's Games

Health officials in China said this week that more than one billion people, or 72 percent of the country's 1.4 billion citizens, have been fully vaccinated.

WHO recommends antibody treatment for COVID-19 infected people who have a high risk of hospitalisation
science

WHO recommends antibody treatment for COVID-19 infected people who have a high risk of hospitalisation

The Regeneron cocktail of synthetic antibodies - casirivimab and imdevimab - has been found to reduce the risk of hospitalisation for unvaccinated, elderly or immunosuppressed patients with Covid.